| 2.77 0.09 (3.36%) | 10-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.1  |
1-year : | 4.74 |
| Resists | First : | 3.51 |
Second : | 4.06 |
| Pivot price | 2.92 |
|||
| Supports | First : | 2.61 |
Second : | 2.17 |
| MAs | MA(5) : | 2.82 |
MA(20) : | 2.97 |
| MA(100) : | 3.74 |
MA(250) : | 3.77 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 12 |
D(3) : | 13.7 |
| RSI | RSI(14): 33.4 |
|||
| 52-week | High : | 5.67 | Low : | 2.15 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ DH ] has closed above bottom band by 12.4%. Bollinger Bands are 38.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.79 - 2.8 | 2.8 - 2.82 |
| Low: | 2.58 - 2.6 | 2.6 - 2.62 |
| Close: | 2.73 - 2.77 | 2.77 - 2.8 |
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Sat, 25 Oct 2025
Definitive Healthcare (NASDAQ:DH) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Thu, 23 Oct 2025
Definitive Healthcare to Report Third Quarter Financial Results on November 6, 2025 - Quiver Quantitative
Sat, 18 Oct 2025
Definitive Healthcare Corp.'s (NASDAQ:DH) 30% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Mon, 13 Oct 2025
What Makes Definitive Healthcare (DH) a New Buy Stock - Nasdaq
Fri, 26 Sep 2025
Definitive Healthcare's Stock Sinks To US$3.85, But Insiders Sold Even Lower - simplywall.st
Tue, 19 Aug 2025
DH vs. BL: Which Stock Should Value Investors Buy Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 104 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 9.3 (%) |
| Held by Institutions | 95.8 (%) |
| Shares Short | 3,810 (K) |
| Shares Short P.Month | 4,410 (K) |
| EPS | -2.7 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.9 |
| Profit Margin | -124.5 % |
| Operating Margin | -5.8 % |
| Return on Assets (ttm) | -0.6 % |
| Return on Equity (ttm) | -67.4 % |
| Qtrly Rev. Growth | -4.7 % |
| Gross Profit (p.s.) | 1.96 |
| Sales Per Share | 2.35 |
| EBITDA (p.s.) | 0.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 63 (M) |
| Levered Free Cash Flow | 70 (M) |
| PE Ratio | -1.03 |
| PEG Ratio | 0 |
| Price to Book value | 0.95 |
| Price to Sales | 1.17 |
| Price to Cash Flow | 4.58 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|